CLL

Showing NaN - NaN of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

Terminated
  • CLL
  • SLL
  • Boston, Massachusetts
  • +1 more
Jan 30, 2023

AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)

Completed
  • AML
  • +8 more
  • Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jul 14, 2016

Chronic Lymphocytic Leukemia, CLL, Untreated Trial in United States (Lenalidomide and Rituximab)

Unknown status
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Lenalidomide and Rituximab
  • La Jolla, California
  • +4 more
Sep 8, 2010